Quantcast
Last updated on April 16, 2014 at 11:25 EDT

Latest McLean Hospital Stories

2014-01-10 08:23:35

BOSTON, Jan. 10, 2014 /PRNewswire/ -- The National Institute of Mental Health has prioritized the development of a rapidly acting treatment for depression as a key research goal. As a result, NIMH created the Rapidly Acting Treatments for Treatment Resistant Depression (RAPID) program to identify and test promising antidepressant interventions. Tal Medical's LFMS technology was selected to be tested in the first trial as part of the RAPID program. Historically, depression treatments...

2013-04-25 16:30:37

Belief in God may significantly improve the outcome of those receiving short-term treatment for psychiatric illness, according to a recent study conducted by McLean Hospital investigators. In the study, published in the current issue of Journal of Affective Disorders, David H. Rosmarin, PhD, McLean Hospital clinician and instructor in the Department of Psychiatry at Harvard Medical School, examined individuals at the Behavioral Health Partial Hospital program at McLean in an effort to...

2012-12-17 14:26:54

Long-term users may experience side effects similar to those seen in people with dementia The long-term use of anabolic-androgenic steroids (AAS) may severely impact the user's ability to accurately recall the shapes and spatial relationships of objects, according to a recent study conducted by McLean Hospital and Harvard Medical School investigators. In the study, published today online in the journal Drug and Alcohol Dependence, McLean Hospital Research Psychiatrist Harrison Pope, MD,...

Chinese Herb Kudzu Reduces Consumption Of Alcohol
2012-05-18 10:29:30

According to a new study published in the current issue of Drug and Alcohol Dependence by McLean Hospital and Harvard Medical School researchers, an extract of the Chinese herb kudzu reduces binge drinking and could be useful in the treatment of alcoholism. David Penetar, PhD, lead author of the study from the Behavioral Psychopharmacology Research Laboratory at McLean Hospital, explains: “Our study is further evidence that components found in kudzu root can reduce alcohol...

2011-11-08 10:33:26

Results of first large-scale study on treatment of prescription opioid addiction are announced Individuals addicted to prescription painkillers are more likely to succeed in treatment with the aid of the medication buprenorphine-naloxone (Suboxone), report McLean Hospital and Harvard Medical School researchers in today's online edition of the Archives of General Psychiatry. "Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid...

2011-08-05 14:00:05

Researchers at Harvard-affiliated McLean Hospital have found that those who believe in a benevolent God tend to worry less and be more tolerant of life's uncertainties than those who believe in an indifferent or punishing God. The paper, recently published in the Journal of Clinical Psychology, which will be presented by lead author David H. Rosmarin, PhD, assistant in psychology at McLean, at the annual meeting of the American Psychological Association on Friday, Aug. 5 in Washington, D.C.,...

a6826f93431f3e53b6202af16315351d1
2011-02-15 07:45:00

Ecstasy use does not impair a person's cognitive function or diminish their mental ability, according to a new study published Tuesday in the journal Addiction. The National Institute on Drug Abuse (NIDA) funded study compared 52 users of Ecstasy, also known as methylenedioxymethamphetamine or MDMA, with 59 non-users. They found that using the drug, which the NIDA says "is chemically similar to the stimulant methamphetamine and the hallucinogen mescaline" and "produces feelings of increased...

2a81b3e12b990bdd1917d85d8d3bb2f3
2010-12-02 15:03:42

U.S. researchers are getting closer to having an accurate test for autism, a finding that could lead to earlier diagnosis and treatment. They reported on Thursday that the test detected 94 percent of individuals with a high-functioning form of autism. "These results are the best yet in the search for a biological basis in terms of being able to distinguish those with and without the disease," Nicholas Lange of Harvard Medical School, who directs the Neurostatistics Laboratory at McLean...

2010-05-27 13:31:14

Researchers at Harvard-affiliated McLean Hospital have produced the first evidence that the opioid blocker extended-release injectable naltrexone (XR-NTX) is able to reduce the brain's response to cues that may cause alcoholics to relapse. In data presented today at the annual meeting of the American Psychiatric Association, Scott Lukas, PhD, director of the Neuroimaging Center at McLean, located in Belmont, Mass., said the findings help in the understanding of how XR-NTX works in reducing...

0ecec18d2d8ccf7327e456f83d537eb31
2009-06-24 08:58:34

Researchers are baffled to find indications that women have more of an issue with looking at babies with facial birth defects than men. Psychiatrists from the Harvard-affiliated McLean Hospital, who were studying perceptions of beauty, had expected quite a different reaction. The study being published on Wednesday raises more questions than it can answer. In a previous study, The McLean team observed men and women viewing photos of adult faces on a computer. The pictures were to be rated...